Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: A cohort study
(2014)
Journal Article
Meakin, G., Anderson, J., McKeever, T., Wilson, E., McKeever, T. M., Hargadon, B., …Shaw, D. E. (2014). Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: A cohort study. European Respiratory Journal, 44(6), 1705-1707. https://doi.org/10.1183/09031936.00093614
All Outputs (3)
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations (2014)
Journal Article
Bateman, E. D., Buhl, R., O’Byrne, P. M., Humbert, M., Reddel, H. K., Sears, M. R., …Eriksson, G. (2015). Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations. Journal of Allergy and Clinical Immunology, 135(6), 1457-1464. https://doi.org/10.1016/j.jaci.2014.08.015
The impact of azithromycin therapy on the airway microbiota in asthma (2014)
Journal Article
Slater, M., Rivett, D. W., Williams, L., Martin, M., Harrison, T. W., Sayers, I., …Shaw, D. E. (2014). The impact of azithromycin therapy on the airway microbiota in asthma. Thorax, 69(7), https://doi.org/10.1136/thoraxjnl-2013-204517There is interest in the use of macrolide antibiotics in asthma. Macrolides have been shown to improve airway hyperresponsiveness (AHR) and measures of airway inflammation.The degree of AHR may relate to the microbiota present in the airways, with a... Read More about The impact of azithromycin therapy on the airway microbiota in asthma.